CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Open-market buy Chief Executive Officer bought 7,500 shares at $8.11 ($60,825)
- 4 Open-market buy 10% owner bought 25,000 shares at $8.03 ($200,735)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 9,778 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 20,000 shares at an average $14.60 ($292,076)
- 4 Open-market buy Chief Executive Officer bought 5,800 shares at $17.05 ($98,890)
- 4 Open-market buy Director bought 20,000 shares at $16.92 ($338,400)
- 4 Shares withheld for taxes Chief Executive Officer gave up 299,968 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 109,080 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 136,350 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 117,633 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 34,442 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 9,602 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 35,179 shares (to pay taxes)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $13.39 ($334,750)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $13.54 ($33,850)
Page 4 of 15 · 296 filings